Search Results - "Brelière, Jean Claude"

  • Showing 1 - 20 results of 20
Refine Results
  1. 1

    SR141716A, a potent and selective antagonist of the brain cannabinoid receptor by Rinaldi-Carmona, Murielle, Barth, Francis, Héaulme, Michel, Shire, David, Calandra, Bernard, Congy, Christian, Martinez, Serge, Maruani, Jeanne, Néliat, Gervais, Caput, Daniel, Ferrara, Pascual, Soubrié, Philippe, Brelière, Jean Claude, Le Fur, Gérard

    Published in FEBS letters (22-08-1994)
    “…SR141716A is the first selective and orally active antagonist of the brain cannabinoid receptor. This compound displays nanomolar affinity for the central…”
    Get full text
    Journal Article
  2. 2

    Biochemical and pharmacological characterisation of SR141716A, the first potent and selective brain cannabinoid receptor antagonist by Rinaldi-Carmona, M, Barth, F, Héaulme, M, Alonso, R, Shire, D, Congy, C, Soubrié, P, Brelière, J C, Le Fur, G

    Published in Life sciences (1973) (1995)
    “…SR141716A is a selective, potent and orally active antagonist of the brain cannabinoid receptor with a long duration of action. This compound shows high…”
    Get more information
    Journal Article
  3. 3

    In vitro and in vivo biological activities of SR140333, a novel potent non-peptide tachykinin NK1 receptor antagonist by Emonds-Alt, X, Doutremepuich, J D, Heaulme, M, Neliat, G, Santucci, V, Steinberg, R, Vilain, P, Bichon, D, Ducoux, J P, Proietto, V

    Published in European journal of pharmacology (21-12-1993)
    “…(S)1-(2-[3-(3,4-dichlorophenyl)-1-(3-isopropoxyphenylacetyl)pip eridin-3- yl]ethyl)-4-phenyl-1-azoniabicyclo[2.2.2]octane chloride (SR140333) is a new…”
    Get more information
    Journal Article
  4. 4

    Blockade of cannabinoid (CB1) receptors by SR 141716 selectively antagonizes drug-induced reinstatement of exploratory behaviour in gerbils by PONCELET, M, BARNOUIN, M.-C, BRELIERE, J.-C, LE FUR, G, SOUBRIE, P

    Published in Psychopharmacologia (20-05-1999)
    “…Rationale: A cannabinoid hypothesis of schi- zophrenia has been proposed according to which cognitive dysfunction could be associated with dysregulation of an…”
    Get full text
    Journal Article
  5. 5

    Characterization and distribution of binding sites for [ 3H]-SR 141716A, a selective brain (CB1) cannabinoid receptor antagonist, in rodent brain by Rinaldi-Carmona, Murielle, Pialot, Françoise, Congy, Christian, Redon, Elsa, Barth, Francis, Bachy, André, Brelière, Jean-Claude, Soubrié, Philippe, Le Fur, Gérard

    Published in Life sciences (1973) (1996)
    “…SR 141716A belongs to a new class of compounds (diarylpyrazole) that inhibits brain carmabinoid receptors (CB1) in vitro and in vivo . The present study showed…”
    Get full text
    Journal Article
  6. 6

    Effect of substance P on cytokine production by human astrocytic cells and blood mononuclear cells: characterization of novel tachykinin receptor antagonists by Derocq, Jean-Marie, Ségui, Michel, Blazy, Chantal, Emonds-Alt, Xavier, Le Fur, Gérard, Brelière, Jean-Claude, Casellas, Pierre

    Published in FEBS letters (16-12-1996)
    “…Substance P (SP) has been reported to induce inflammatory cytokine production in human neuroglial cells and peripheral lymphoid cells as well. In order to…”
    Get full text
    Journal Article
  7. 7
  8. 8

    Immunopharmacological profile of SR 31747: in vitro and in vivo studies on humoral and cellular responses by Casellas, P, Bourrié, B, Canat, X, Carayon, P, Buisson, I, Paul, R, Brelière, J C, Le Fur, G

    Published in Journal of neuroimmunology (01-07-1994)
    “…In our preceding paper, we demonstrated that both human and rat lymphocytes possess saturable high-affinity binding sites for the new sigma ligand SR 31747…”
    Get more information
    Journal Article
  9. 9

    Allosteric modulation of peripheral sigma binding sites by a new selective ligand: SR 31747 by Paul, R, Lavastre, S, Floutard, D, Floutard, R, Canat, X, Casellas, P, Le Fur, G, Brelière, J C

    Published in Journal of neuroimmunology (01-07-1994)
    “…The interactions of a new compound SR 31747 with sigma sites were examined in rat spleen membranes and in human peripheral blood leukocytes (PBL). Nanomolar…”
    Get more information
    Journal Article
  10. 10

    Turning behavior induced in mice by a neurokinin A receptor agonist: stereoselective blockade by SR 48968, a non-peptide receptor antagonist by Poncelet, M, Gueudet, C, Emonds-Alt, X, Brelière, J C, Le Fur, G, Soubrié, P

    Published in Neuroscience letters (04-01-1993)
    “…The intrastriatal injection of [Nle10]-NKA(4-10), a neurokinin A agonist, (0.05-5 ng/mouse) elicited vigorous contralateral rotations. This behavior was…”
    Get more information
    Journal Article
  11. 11

    The NK2 receptor antagonist SR48968 inhibits thalamic responses evoked by thermal but not mechanical nociception by Santucci, V, Gueudet, C, Edmonds-Alt, X, Brelière, J C, Soubrié, P, Le Fur, G

    Published in European journal of pharmacology (11-06-1993)
    “…Extracellular recordings were made in the thalamic posterior nuclear group of anesthetized rats to study the effects of SR48968, a non-peptide NK2 receptor…”
    Get more information
    Journal Article
  12. 12

    Identification of binding sites for SR 46349B, a 5-hydroxytryptamine2 receptor antagonist, in rodent brain by Rinaldi-Carmona, M, Congy, C, Pointeau, P, Vidal, H, Brelière, J C, Le Fur, G

    Published in Life sciences (1973) (1994)
    “…SR 46349B belongs to a new class of compounds (propenone oxime ether derivative) that inhibit 5-hydroxytryptamine (HT)2 receptors in vitro and in vivo. (3H) SR…”
    Get more information
    Journal Article
  13. 13
  14. 14

    SR 144528, the first potent and selective antagonist of the CB2 cannabinoid receptor by Rinaldi-Carmona, M, Barth, F, Millan, J, Derocq, J M, Casellas, P, Congy, C, Oustric, D, Sarran, M, Bouaboula, M, Calandra, B, Portier, M, Shire, D, Brelière, J C, Le Fur, G L

    “…Based on both binding and functional data, this study introduces SR 144528 as the first, highly potent, selective and orally active antagonist for the CB2…”
    Get more information
    Journal Article
  15. 15

    Effects of 1-hydroxyethylidene-1,1 bisphosphonate and (chloro-4 phenyl) thiomethylene bisphosphonic acid (SR 41319) on the mononuclear cell factor-mediated release of neutral proteinases by articular chondrocytes and synovial cells by Emonds-Alt, X, Brelière, J C, Roncucci, R

    Published in Biochemical pharmacology (15-11-1985)
    “…Articular chondrocytes and synovial cells were stimulated to produce collagenase, neutral casein and proteoglycan-degrading proteinases by conditioned medium…”
    Get more information
    Journal Article
  16. 16

    Tachykinin-induced contractions of the guinea pig ileum longitudinal smooth muscle: tonic and phasic muscular activities by Vilain, P, Emonds-Alt, X, Le Fur, G, Brelière, J C

    “…In vitro tachykinin-induced contractions of guinea pig ileum longitudinal smooth muscle were investigated under isometric conditions by using selective…”
    Get more information
    Journal Article
  17. 17

    Two nonpeptide tachykinin antagonists act through epitopes on corresponding segments of the NK1 and NK2 receptors by U Gether, Y Yokota, X Emonds-Alt, J C Brelière, J A Lowe, 3rd, R M Snider, S Nakanishi, T W Schwartz

    “…The molecular mechanism of action for two chemically distinct and highly selective, nonpeptide antagonists, CP-96,345 and SR-48,968, was studied by development…”
    Get full text
    Journal Article
  18. 18

    Evidence for a common molecular mode of action for chemically distinct nonpeptide antagonists at the neurokinin-1 (substance P) receptor by Gether, U, Emonds-Alt, X, Brelière, J C, Fujii, T, Hagiwara, D, Pradier, L, Garret, C, Johansen, T E, Schwartz, T W

    Published in Molecular pharmacology (01-03-1994)
    “…The molecular mechanism of action of three chemically distinct nonpeptide antagonists, SR 140,333, FK 888, and RP 67,580, was compared with that of the…”
    Get more information
    Journal Article
  19. 19

    Effects on the isolated human bronchus of SR 48968, a potent and selective nonpeptide antagonist of the neurokinin A (NK2) receptors by Advenier, C, Naline, E, Toty, L, Bakdach, H, Emonds-Alt, X, Vilain, P, Brelière, J C, Le Fur, G

    Published in The American review of respiratory disease (01-11-1992)
    “…Tachykinins produce concentration-dependent contraction of the human isolated bronchus by stimulation of receptors that belong to the NK2 type. The aim of this…”
    Get more information
    Journal Article
  20. 20

    Two Nonpeptide Tachykinin Antagonists Act Through Epitopes on Corresponding Segments of the NK1and NK2Receptors by Gether, Ulrik, Yokota, Yoshifumi, Emonds-Alt, Xavier, Breliere, Jean-Claude, Lowe, John A., Snider, R. Michael, Nakanishi, Shigetada, Schwartz, Thue W.

    “…The molecular mechanism of action for two chemically distinct and highly selective, nonpeptide antagonists, CP-96,345 and SR-48,968, was studied by development…”
    Get full text
    Journal Article